Drug Type Small molecule drug |
Synonyms ML315 |
Target |
Action inhibitors |
Mechanism CLK1 inhibitors(CDC like kinase 1 inhibitors), CLK4 inhibitors(CDC like kinase 4 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H13Cl2N3O2 |
InChIKeyJQSJAVBMIMDUFO-UHFFFAOYSA-N |
CAS Registry1440251-53-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Down Syndrome | Preclinical | United States | 08 May 2013 | |
Neoplasms | Preclinical | United States | 08 May 2013 |